Influenza places a significant burden on global health and economics. Individual case management and public health efforts to mitigate the spread of influenza are both strongly impacted by our ability ...

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,394,608 covering the company’s FilmArray ...

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc. today announced that it has submitted the FilmArray Blood Culture Identification (BCID) Panel to the U.S. Food and Drug Administration (FDA) ...

Acupath Labs a leading provider of sub-specialized anatomic and molecular pathology services, launches the BioFire® FilmArray® GI Panel, a FDA-cleared PCR based panel that tests for 22 of the most ...

The highly contagious nature of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus Disease 2019 (COVID-19), requires rapid diagnostic tests to prevent ...

June 7, 2013 -- BioFire Diagnostics Inc. announced today that it obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its FilmArray Blood Culture ...

AN innovative, rapid test for meningitis is now being used at Worcester hospital which speeds up diagnosis and saves lives. Accurate results come in within an hour as part of a test to help head off ...